Skip to main content
. 2020 Jul 7;11:1368. doi: 10.3389/fimmu.2020.01368

Figure 3.

Figure 3

Secondary prevention. Prophylactic vaccination to prevent the transition from clinically silent IgE sensitization to the development of allergic symptoms. Children showing allergen-specific IgE reactivity are vaccinated in order to induce and maintain the production of blocking allergen-specific IgG antibodies to prevent the development of allergic symptoms.